When available, the Online Course format is included with the hard copy, eBook, or audio book formats!
Note: This course must be completed by 12/31/16. Contact hours will not be awarded beyond this date.
In this course, nurses will gain essential information to build a safe and effective practice for administering respiratory medications. The course opens with a discussion of pharmacological principles, including drug interactions and phases of drug action. The discussion of drug dose calculations begins with a review of the metric system. Nurses will learn about making calculations with a dose schedule as well as calculations from percent strength solutions. Medicated aerosol therapy is described, and aerosol delivery devices are reviewed. The discussion of bronchodilators includes a description of the autonomic nervous system, including cellular action and airway and cardiac responses. Nurses will learn about adrenergic bronchodilators, anticholinergic bronchodilators, and methylxanthines (phosphodiesterase inhibitors). The discussion of mucus-controlling agents begins with a review of the mucociliary system and then describes bland aerosols and mucoactive agents. The section on exogenous surfactant agents includes a description of alveolar physiology and surfactant synthesis. Nurses will learn about corticosteroids, the nature of the inflammatory response, the clinical application of aerosolized steroids, and exogenous corticosteroid agents. The immunological response to nonsteroidal anti-inflammatory agents is described, as are aerosolized anti-infective agents, including antiviral, antiprotozoal, and antibiotic agents. Finally, the course covers aerosolized/gaseous pulmonary vasodilators and their indications for the use.
Kentucky APRNs - This course fulfills your pharmacology CE requirement
- Define key terms related to general pharmacological principles.
- Calculate drug doses using percentage-strength solutions and dosage schedules.
- Describe the factors that affect aerosol deposition in the lungs.
- Compare modes of action indications and adverse effects that characterize the major classes of aerosolized and non-aerosolized respiratory pharmacologic agents.
- Recommend the appropriate respiratory pharmacologic agent and delivery method based on patient clinical presentation.
Sindee K. Karpel, MPA, RRT, is the clinical coordinator for the Respiratory Care Program and professor in the Cardiopulmonary Sciences Program at Edison State College, Fort Myers, Florida.
Ms. Karpel received her baccalaureate degree from Queens College of the City University of New York, her certificate in Respiratory Care from the New York University Medical Center/Bellevue Hospital Respiratory Therapy Program, and her master’s of public administration with a major in health care administration from Long Island University. She has been a full-time respiratory care educator since 1993 and has been teaching respiratory care pharmacology since that time.
Ms. Karpel is the author of several articles on various respiratory care topics, two well-known respiratory care workbooks, and test-banks for popular respiratory care textbooks.
- Contact hours will be awarded for up to one (1) year from the date the course is ordered.
- You must score 75% or higher on the final exam and complete the course evaluation to pass this course and receive a certificate of completion.
- Through our review processes, Western Schools ensures that this course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Western Schools’ policy not to accept commercial support.
- All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.